EGFR and colon adenocarcinoma: Enhanced activity of AP-1 has been demonstrated in human colon adenocarcinoma and the immune-histochemical analysis of majority of colon adenocarcinoma has revealed high-level expression of AP-1 correlating with the high expression of its downstream targets like EGFR and COX-2 [46].